Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort

International Journal of Epidemiology

Volumn 32, Issue 4, 2003, Pages 607-614

  La Batide Alanore, Agnès ^a   Trégouët, David Alexandre ^a   Sass, Catherine ^a   Siest, Gérard ^a   Visvikis, Sophie ^a   Tiret, Laurence ^a  

^a INSERM   (France)

Author keywords

Blood pressure; Correlation; Family; Height; Lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BODY SIZE; CARDIOVASCULAR DISEASE; HEALTH RISK; HEIGHT; RISK FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILY STUDY; FATHER; FEMALE; GENETIC TRAIT; HEREDITY; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL EXAMINATION; MOTHER; PARENT; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PUBERTY; SAMPLE; SEXUAL MATURATION; SHORT STATURE; SYSTOLIC BLOOD PRESSURE; VOLUNTEER;

EID: 0042385128     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyg110     Document Type: Article

References (37)

1. Peck AM, Vagero DH. Adult body height, self perceived health and mortality in the Swedish population. J Epidemiol Community Health 1989;43:380-84.
2. Palmer JR, Rosenberg L, Shapiro S. Stature and the risk of myocardial infarction in women. Am J Epidemiol 1990;132:27-32.
3. Davey Smith G, Shipley MJ, Rose G. Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study. J Epidemiol Community Health 1990;44:265-70.
4. Yarnell JW, Limb ES, Layzell JM, Baker IA. Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies. Eur Heart J 1992;13:1602-05.
5. Hebert PR, Rich-Edwards JW, Manson JE et al. Height and incidence of cardiovascular disease in male physicians. Circulation 1993;88: 1437-43.
6. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. Evidence that height is an independent risk factor for coronary artery disease (the Manitoba Follow-Up Study). Am J Cardiol 1994;74:398-99.
7. Kannam J, Levy D, Larson M, Wilson P. Short stature and risk for mortality and cardiovascular disease events. The Famingham Heart Study. Circulation 1994;90:2241-47.
8. Parker DR, Lapane KL, Lasater TM, Carleton RA. Short stature and cardiovascular disease among men and women from two southeastern New England communities. Int J Epidemiol 1998;27:970-75.
9. Wamala SP, Mittleman MA, Horsten M, Schenck-Gustafsson K, Orth-Gomer K. Short stature and prognosis of coronary heart disease in women. J Intern Med 1999;245:557-63.
10. Notkola V, Punsar S, Karvonen MJ, Haapakoski J. Socio-economic conditions in childhood and mortality and morbidity caused by coronary heart disease in adulthood in rural Finland. Soc Sci Med 1985;21:517-23.
11. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36:62-67.
12. Kee F, Nicaud V, Tiret L, Evans A, O'Reilly D, De Backer G. Short stature and heart disease: nature or nurture? The EARS Group. Int J Epidemiol 1997;26:748-56.
13. Rosseneu M, Fruchart JC, Bard JM et al. on behalf of the EARS Group. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects - The EARS Study. Circulation 1994;89:1967-73.
14. Silventoinen K, Kaprio J, Lahelma E, Koskenvuo M. Relative effect of genetic and environmental factors on body height: differences across birth cohorts among Finnish men and women. Am J Public Health 2000;90:627-30.
15. Hirschhorn JN, Lindgren CM, Daly MJ et al. Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height. Am J Hum Genet 2001; 69:106-16.
16. Friedlander Y, Kark JD, Stein Y. Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic. Hum Hered 1986;36:143-53.
17. Clarke WR, Schrott HG, Burns TL, Sing CF, Lauer RM. Aggregation of blood pressure in the families of children with labile high systolic blood pressure. The Muscatine Study. Am J Epidemiol 1986;123:67-80.
18. Knuiman MW, Divitini ML, Welborn TA, Bartholomew HC. Familial correlations, cohabitation effects, and heritability for cardiovascular risk factors. Ann Epidemiol 1996;6:188-94.
19. Mitchell BD, Kammerer CM, Blangero J et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 1996;94:2159-70.
20. Rice T, Nadeau A, Perusse L, Bouchard C, Rao DC. Familial correlations in the Quebec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia 1996;39:1357-64.
21. Tregouet DA, Herbeth B, Juhan-Vague I, Siest G, Ducimetiere P, Tiret L. Bivariate familial correlation analysis of quantitative traits by use of estimating equations: application to a familial analysis of the insulin resistance syndrome. Genet Epidemiol 1999;16:69-83.
22. Siest G, Visvikis S, Herbeth B et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 1998;36:35-42.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
24. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991;133:884-99.
25. Bergstrom E, Hernell O, Persson LA, Vessby B. Serum lipid values in adolescents are related to family history, infant feeding, and physical growth. Atherosclerosis 1995;117:1-13.
26. Uiterwaal CS, Witteman JC, de Bruijn AM, Hofman A, Grobbee DE. Families and natural history of lipids in childhood: an 18-year follow-up study. Am J Epidemiol 1997;145:777-85.
27. van Lenthe FJ, van Mechelen W, Kemper HC, Twisk JW. Association of a central pattern of body fat with blood pressure and lipoproteins from adolescence into adulthood. The Amsterdam Growth and Health Study. Am J Epidemiol 1998;147:686-93.
28. Hong Y, Pedersen NL, Brismar K, de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 1997;60:143-52.
29. Brotons C, Singh P, Nishio T, Labarthe DR. Blood pressure by age in childhood and adolescence: a review of 129 surveys worldwide. Int J Epidemiol 1989;18:824-29.
30. Acheson D. Nutritional monitoring of the health of the Nation. J Soc Health 1987;6:209-14.
31. Power C, Manor O, Fox J. Health and Class: The Early Years. London: Chapman and Hall, 1991.
32. Vagero D, Leon D. Ischaemic heart disease and low birth weight: a test of the fetal-origins hypothesis trom the Swedish Twin Registry. Lancet 1994;343:260-63.
33. Allison DB, Paultre F, Heymsfield SB, Pi-Sunyer FX. Is the intrauterine period really a critical period for the development of adiposity? Int J Obes Relat Metab Disord 1995;19:397-402.
34. Fant ME, Weisoly D. Insulin and insulin-like growth factors in human development: implications for the perinatal period. Semin Perinatol 2001;25:426-35.
35. Jiang X, Srinivasan SR, Dalferes ER Jr, Berenson GS. Plasma insulin-like growth factor 1 distribution and its relation to blood pressure in adolescents: the Bogalusa Heart Study. Am J Hypertens 1997;10: 714-19.
36. Verdecchia P, Reboldi G, Schillaci G et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999;100:1802-07.
37. Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res 2000; 86:125-30.